ATE327770T1 - Zellulosepartikel für eine pharmazeutische zusammensetzung - Google Patents

Zellulosepartikel für eine pharmazeutische zusammensetzung

Info

Publication number
ATE327770T1
ATE327770T1 AT01979030T AT01979030T ATE327770T1 AT E327770 T1 ATE327770 T1 AT E327770T1 AT 01979030 T AT01979030 T AT 01979030T AT 01979030 T AT01979030 T AT 01979030T AT E327770 T1 ATE327770 T1 AT E327770T1
Authority
AT
Austria
Prior art keywords
cellulose particles
pharmaceutical composition
less
cellulose
pharmaceutical
Prior art date
Application number
AT01979030T
Other languages
English (en)
Inventor
Shun Ichi Gomi
Etsuo Kamada
Yuuji Hirano
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE327770T1 publication Critical patent/ATE327770T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B16/00—Regeneration of cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AT01979030T 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung ATE327770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000338243 2000-11-06

Publications (1)

Publication Number Publication Date
ATE327770T1 true ATE327770T1 (de) 2006-06-15

Family

ID=18813481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979030T ATE327770T1 (de) 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung

Country Status (12)

Country Link
US (1) US20040043964A1 (de)
EP (1) EP1338288B1 (de)
JP (1) JP4062436B2 (de)
KR (1) KR100526285B1 (de)
CN (1) CN1222318C (de)
AT (1) ATE327770T1 (de)
AU (2) AU2002211018B2 (de)
BR (1) BR0115058A (de)
CA (1) CA2427991C (de)
DE (1) DE60120211T2 (de)
TW (1) TWI290471B (de)
WO (1) WO2002036168A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527686C (en) 2003-05-30 2009-11-03 Asahi Kasei Chemicals Corporation Cellulose powder
WO2005073286A1 (ja) 2004-01-30 2005-08-11 Asahi Kasei Chemicals Corporation 多孔質セルロース凝集体及びその成型体組成物
CN101203553B (zh) * 2005-04-22 2011-05-18 旭化成化学株式会社 多孔纤维素聚集体及其成型组合物
US20080013047A1 (en) * 2006-06-30 2008-01-17 Novavision, Inc. Diagnostic and Therapeutic System for Eccentric Viewing
JP5160423B2 (ja) * 2006-07-19 2013-03-13 旭化成ケミカルズ株式会社 水易溶性薬物含有球状素顆粒の製造方法
EP2050438B1 (de) * 2006-07-26 2016-10-19 Asahi Kasei Kabushiki Kaisha Kugelförmiges grobes granulat und herstellungsverfahren dafür
WO2008112565A2 (en) * 2007-03-09 2008-09-18 Anthony Manganaro Method and composition for treating cancer
JP5461179B2 (ja) * 2007-06-06 2014-04-02 旭化成ケミカルズ株式会社 セルロース系微小核粒子及びその製造方法
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CA2702055C (en) * 2007-10-10 2017-12-12 Mallinckrodt Baker, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
JP2009155215A (ja) * 2007-12-25 2009-07-16 Freunt Ind Co Ltd 球形粒及びその製造方法並びに放出制御製剤の製造方法
JP2009263303A (ja) * 2008-04-28 2009-11-12 Freunt Ind Co Ltd 球形顆粒及びその製造方法
US9132195B2 (en) 2008-05-21 2015-09-15 Asahi Kasei Chemicals Corporation Cellulose powder having excellent segregation preventive effect, and compositions thereof
US8529953B2 (en) * 2008-07-01 2013-09-10 Sawai Pharmaceutical Co., Ltd. Process for production of spherical microparticles comprising tamsulosin hydrochloride
US20110288146A1 (en) * 2008-11-19 2011-11-24 Nandu Deorkar Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof
MY155971A (en) 2009-10-22 2015-12-30 Asahi Kasei Chemicals Corp Methacrylic resin, molded body thereof, and method for producing methacrylic resin
JP2011207851A (ja) * 2010-03-30 2011-10-20 Asahi Kasei Chemicals Corp 膨潤性の球状核
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
ES2642312T3 (es) * 2011-08-04 2017-11-16 Flexion Therapeutics, Inc. Corticosteroides para el tratamiento del dolor de articulaciones
WO2015084696A1 (en) * 2013-12-04 2015-06-11 Dow Global Technologies Llc Process for preparing a mixture of a cellulose derivative and a liquid diluent
JP6216074B2 (ja) * 2014-08-12 2017-10-18 旭化成株式会社 微小セルロース粉末
JP5877889B2 (ja) * 2014-11-07 2016-03-08 旭化成ケミカルズ株式会社 膨潤性の球状核
CN108603092A (zh) * 2015-11-30 2018-09-28 株式会社发展合伙 固液混合物的流动性降低剂以及低流动性混合物的制造方法
JP6366794B2 (ja) * 2016-07-28 2018-08-01 大原薬品工業株式会社 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
GB201715387D0 (en) 2017-09-22 2017-11-08 Cambridge Entpr Ltd Treatment of polymer particles
BR112021001402A2 (pt) * 2018-07-27 2021-04-27 Chiesi Farmaceutici S.P.A. novas partículas carreadoras para formulações de pó seco para inalação
JP7199871B2 (ja) * 2018-08-10 2023-01-06 日揮触媒化成株式会社 多孔質セルロース粒子とその製造方法、および洗浄用化粧料
JP7265331B2 (ja) * 2018-09-28 2023-04-26 日揮触媒化成株式会社 多孔質セルロース粒子および化粧料
BR112021011263A2 (pt) 2018-12-27 2021-08-31 Asahi Kasei Kabushiki Kaisha Pó de celulose, uso do mesmo, e comprimidos
JP7149885B2 (ja) * 2019-03-22 2022-10-07 株式会社ダイセル セルロース誘導体粒子、化粧品組成物及びセルロース誘導体粒子の製造方法
BR112021021232A2 (pt) * 2019-04-25 2021-12-21 Fuji Pharma Co Ltd Preparação farmacêutica na forma de grânulos, preparação, método de produção de uma preparação farmacêutica e métodos para a produção de comprimidos e para a produção de cápsulas
US11957165B2 (en) 2019-07-05 2024-04-16 Swedish Match North Europe Ab Oral pouched nicotine product including a filling material comprising nicotine-containing particles
US20220400735A1 (en) 2019-11-20 2022-12-22 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine particles
JP2021095470A (ja) * 2019-12-16 2021-06-24 王子ホールディングス株式会社 粉末状セルロース
CN113480669B (zh) * 2021-07-13 2022-08-12 安徽山河药用辅料股份有限公司 一种低松密度交联羧甲纤维素钠的制备方法
CN117122069B (zh) * 2022-05-19 2026-02-13 仙乐健康科技股份有限公司 一种颗粒和包含所述颗粒的酸性食品
JP2024110729A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
JP2024110728A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
CN117686671B (zh) * 2023-12-11 2024-09-13 国药集团容生制药有限公司 一种优化恩格列净片剂溶出曲线及体内生物等效性的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
JP2976116B2 (ja) * 1989-09-27 1999-11-10 旭化成工業株式会社 球状セルロース粒子の製造方法
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
US5322702A (en) * 1992-06-15 1994-06-21 Fmc Corporation Microgranular protein opacifying material
US5417984A (en) * 1992-12-14 1995-05-23 Biocontrol, Inc. Low crystallinity cellulose excipients
KR100496749B1 (ko) * 2000-07-05 2005-06-22 아사히 가세이 가부시키가이샤 셀룰로스 분말

Also Published As

Publication number Publication date
EP1338288B1 (de) 2006-05-31
EP1338288A4 (de) 2004-12-29
EP1338288A1 (de) 2003-08-27
AU2002211018B2 (en) 2004-08-05
CN1222318C (zh) 2005-10-12
DE60120211D1 (de) 2006-07-06
CN1473054A (zh) 2004-02-04
JPWO2002036168A1 (ja) 2004-03-18
WO2002036168A1 (en) 2002-05-10
TWI290471B (en) 2007-12-01
CA2427991C (en) 2008-01-22
BR0115058A (pt) 2003-10-28
DE60120211T2 (de) 2007-04-12
KR100526285B1 (ko) 2005-11-08
JP4062436B2 (ja) 2008-03-19
US20040043964A1 (en) 2004-03-04
CA2427991A1 (en) 2003-05-05
KR20030051773A (ko) 2003-06-25
AU1101802A (en) 2002-05-15

Similar Documents

Publication Publication Date Title
ATE327770T1 (de) Zellulosepartikel für eine pharmazeutische zusammensetzung
ATE270097T1 (de) Partikulärer wirkstoffträger für die pulmonale applikation
CA2521007A1 (en) Particulate material containing thermoplastic elastomer and methods for making and using same
CO4920214A1 (es) Composiciones que contienen tetrahidrolipstatina
BRPI0518310A2 (pt) materiais em partÍculas de alumina transitàrias tendo morfologia e processamento controlados para a formaÇço dos mesmos
MXPA01003255A (es) Manitol pulverulento y su procedimiento de preparacion.
HRP20000434B1 (en) Celecoxib compositions
MXPA04002540A (es) Material impermeable que comprende particulas metalicas nanodimensionadas.
GR3031843T3 (en) Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses
AU6514398A (en) Absorbent members for body fluids using hydrogel-forming absorbent polymer
ATE208607T1 (de) Granuläre zusammenzetzungen
ATE364381T1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
ID28780A (id) Komposisi granul
GB2396627A (en) Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same
NO20001794D0 (no) Fremgangsmåte ved fremstilling av partikkelformig polymer
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
DE60312670D1 (de) Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
CA2033418A1 (en) Pharmaceutical preparation for oral administration in fluid form
WO2006034397A3 (en) Coating composition
AU2002314972A1 (en) Compressible guaifenesin compositions and method for producing them
EP0665265A3 (de) Zusammensetzungen, enthaltend Metallpartikel im Nanometergrössenbereich.
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
NZ521966A (en) Coating composition having thermal properties
DE60102251D1 (de) Kompaktes 2,2-dibrom-3-nitrilo-propionamid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties